These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 15171360)

  • 1. [Involvement of calcium channels in the pathogenesis of hypertension].
    Murakami M; Iijima T
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():152-5. PubMed ID: 15171360
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of calcium on vascular smooth muscle tone.
    Morgan KG; Suematsu E
    Am J Hypertens; 1990 Dec; 3(12 Pt 2):291S-298S. PubMed ID: 2078315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Do the newer calcium channel blockers replace the older ones?].
    Jounela A
    Duodecim; 1993; 109(20):1815-20. PubMed ID: 7737004
    [No Abstract]   [Full Text] [Related]  

  • 4. [The effect of membrane channel agonists and antagonists on hemodynamics and vascular tonus].
    Shevchuk VH; Iahupol's'kyĭ LM; Shavaran SS; Klebanov BM; Zyma SV
    Fiziol Zh (1994); 1999; 45(1-2):35-9. PubMed ID: 10202634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The voltage-dependent non-selective cation channel sensitive to the L-type calcium channel blocker efonidipine regulates Ca2+ influx in brain vascular smooth muscle cells.
    Matsuoka T; Nishizaki T; Nomura T
    Biochem Biophys Res Commun; 1997 Nov; 240(2):484-7. PubMed ID: 9388505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antihypertensive therapy and vascular wall protection with special reference to calcium antagonists].
    Faulhaber HD
    Z Arztl Fortbild (Jena); 1993; 87(9 Suppl 5):1-5. PubMed ID: 8237075
    [No Abstract]   [Full Text] [Related]  

  • 7. From channels to cats: an overview of isradipine pharmacology.
    Rüegg UT; Hof RP
    Cor Vasa; 1990; 32(2 Suppl 1):12-22. PubMed ID: 2166635
    [No Abstract]   [Full Text] [Related]  

  • 8. [Role of calcium antagonists in the treatment of arterial hypertension].
    Velasco M; Negrín C
    Invest Clin; 1997 Nov; 38 Suppl 2():65-72. PubMed ID: 9471233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Calcium antagonists: current and future applications based on new evidence. Cardio-protective effect of calcium antagonists].
    Hongo K; Yoshimura M
    Clin Calcium; 2010 Jan; 20(1):89-93. PubMed ID: 20048439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Advance in calcium channel blockers relaxing corpus cavernosum smooth muscle].
    Xiao HJ; Liu JH
    Zhonghua Nan Ke Xue; 2003 Feb; 9(1):55-7. PubMed ID: 12680335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hypertensive patients can benefit from a new generation of calcium channel blockers. Lercanidipine: effective with few side effects].
    Borghi C
    Rev Med Suisse; 2006 May; 2(65):1266-7. PubMed ID: 16767882
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of a new calcium antagonist on hemodynamics at rest and exercise loading in patients with essential hypertension.
    Suzuki S; Hashimoto T; Kusano S; Kapuku K; Utsunomiya T; Yano K
    Arzneimittelforschung; 1993 Nov; 43(11):1152-6. PubMed ID: 8292057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcium-entry blockers, vascular smooth muscle and systemic hypertension.
    Vanhoutte PM
    Am J Cardiol; 1985 Jan; 55(3):17B-23B. PubMed ID: 3881910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute hypertension and calcium-channel blockers.
    Kanneganti M; Halpern NA
    New Horiz; 1996 Feb; 4(1):19-25. PubMed ID: 8689271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dihydropyridines and vascular diseases.
    Tamargo J; Delpón E
    Z Kardiol; 1991; 80 Suppl 7():106-11. PubMed ID: 1792815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Calcium channel-blockers for managing metabolic syndrome-associated hypertension. Trials with manidipine].
    Martínez Martín FJ
    Nefrologia; 2007; 27 Suppl 6():26-35. PubMed ID: 18225601
    [No Abstract]   [Full Text] [Related]  

  • 17. Acute hypercalcemia-induced hypertension: the roles of calcium channel and alpha-1 adrenergic receptor.
    Eiam-Ong S; Eiam-Ong S; Punsin P; Sitprija V; Chaiyabutr N
    J Med Assoc Thai; 2004 Apr; 87(4):410-8. PubMed ID: 15217180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [New findings on calcium antagonism].
    Ferrari R; Ceconi C; Curello S; Visioli O
    Ann Ital Med Int; 1992; 7(3 Suppl):100S-111S. PubMed ID: 1338419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcium antagonists in the treatment of hypertension. An international symposium held in Basel, Switzerland, February 10-12, 1988.
    Widimský J; Uhlír O
    Cor Vasa; 1988; 30(5):376-80. PubMed ID: 2852575
    [No Abstract]   [Full Text] [Related]  

  • 20. [Calcium kinetics and effects of calcium antagonist on vascular smooth muscle].
    Aoki K; Miyagawa K
    Nihon Rinsho; 1989 Aug; 47(8):1746-52. PubMed ID: 2585737
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.